Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) FCF Margin % : -20.47% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Bailing Group Pharmaceutical Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Guizhou Bailing Group Pharmaceutical Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-273 Mil. Guizhou Bailing Group Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥1,333 Mil. Therefore, Guizhou Bailing Group Pharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2024 was -20.47%.

As of today, Guizhou Bailing Group Pharmaceutical Co's current FCF Yield % is -2.79%.

The historical rank and industry rank for Guizhou Bailing Group Pharmaceutical Co's FCF Margin % or its related term are showing as below:

SZSE:002424' s FCF Margin % Range Over the Past 10 Years
Min: -9.13 Med: 12.19 Max: 19.01
Current: -3.61

During the past 13 years, the highest FCF Margin % of Guizhou Bailing Group Pharmaceutical Co was 19.01%. The lowest was -9.13%. And the median was 12.19%.

SZSE:002424's FCF Margin % is ranked worse than
59.38% of 1029 companies
in the Drug Manufacturers industry
Industry Median: 0.05 vs SZSE:002424: -3.61

Guizhou Bailing Group Pharmaceutical Co FCF Margin % Historical Data

The historical data trend for Guizhou Bailing Group Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Bailing Group Pharmaceutical Co FCF Margin % Chart

Guizhou Bailing Group Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

12.12

14.72

-3.24

12.25

0.51

Guizhou Bailing Group Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-8.10	12.18	-24.24	15.98	-20.47

Competitive Comparison of Guizhou Bailing Group Pharmaceutical Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Guizhou Bailing Group Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guizhou Bailing Group Pharmaceutical Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guizhou Bailing Group Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Guizhou Bailing Group Pharmaceutical Co's FCF Margin % falls into.

Guizhou Bailing Group Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Guizhou Bailing Group Pharmaceutical Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	21.649	/	4262.971
	=	0.51 %

Guizhou Bailing Group Pharmaceutical Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-272.85	/	1332.744
	=	-20.47 %

Guizhou Bailing Group Pharmaceutical Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Guizhou Bailing Group Pharmaceutical Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Bailing Group Pharmaceutical Co Ltd (SZSE:002424) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Economic and Technological Development Zone, Air Boulevard West, Anshun City, CHN, 561000

Website

http://www.gzbl.com

Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company. It is engaged in the production and sale of medicinal tablets, capsules, and syrups.

Executives

Jiang Wei	Director
Jiang Yong	Directors, executives
Chen Pei	Directors, executives
Kuang Xun Hua	Director
Niu Min	Directors, Directors, and Executives
Chen Zhi	Securities Affairs Representative
Zheng Rong	Executives
Li Qiang	Supervisors
Xia Wen	Supervisors
Wang Xiao Dong	Supervisors
Teng Chun Jie	Supervisors
Li Hui Fang	Supervisors
Zhang Jin Fen	Director
Cai Shou Xian	Executives

Guizhou Bailing Group Pharmaceutical Co (SZSE:002424) Headlines

No Headlines